Inventor

RZESZOTARSKI WACLAW J

US19 patents

⚠️ This page may combine multiple inventors who share the name “RZESZOTARSKI WACLAW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RZESZOTARSKI WACLAW J

NOVA PHARM CORP

Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists

Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists

Antagonists of specific excitatory amino acid neurotransmitter receptors

Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency

Antagonists of specific excitatory amino acid receptors as neuroprotectants and anxiolytics

MARION LABORATORIES INC

1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts

8-arylxanthines

2-aminomethylalkynylalkyl-1,3-dithiane derivatives

Isomers of 1-azabicyclo(2.2.2)oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate

MARION MERRELL DOW INC

Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines

8-(oxo-substituted cycloalkyl)xanthines

Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists

1,7-substituted heptyn-2-ones and use

RESEARCH CORP

3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors

Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; methods of preparation thereof and imaging and assay methods utilizing same

GUILFORD PHARM INC

ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors

Intermediates for making sigma binding site agents

SCIOS NOVA INC

Sigma binding site agents

UNIV GEORGE WASHINGTON

Process for preparing iodovinyl-estradiol